R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

This study has been completed.
Sponsor:
Collaborator:
Amgen
Information provided by (Responsible Party):
Lymphoma Study Association
ClinicalTrials.gov Identifier:
NCT00144755
First received: September 2, 2005
Last updated: September 1, 2015
Last verified: September 2015